Shares of Bruker Corp. (BRKR) plummeted as much as 5.86% in pre-market trading on Monday, following the release of the company's third-quarter 2024 financial results.
The scientific instruments and analytical solutions provider reported adjusted earnings per share of $0.60 for the quarter, narrowly beating analysts' expectations of $0.59. However, revenue of $864.4 million, while surpassing the consensus estimate of $859.4 million, fell short of investors' expectations.
More concerning, Bruker's full-year 2024 revenue guidance range of $3.34 billion to $3.37 billion fell below the analyst consensus of $3.40 billion, indicating potential headwinds or weak demand in the company's core markets.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。